Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

PCNA-LI, Ki-67 Immunostaining, p53 Activity and Histopathological Variables in Predicting the Clinical Outcome in Patients with Parathyroid Carcinoma

FRANCO LUMACHI, MARIO ERMANI, FILIPPO MARINO, MAURIZIO IACOBONE, MONICA BALDESSIN, GIANLUCA CAPPUZZO, SIMONE ZANELLA and GENNARO FAVIA
Anticancer Research March 2006, 26 (2A) 1305-1308;
FRANCO LUMACHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: flumachi@unipd.it
MARIO ERMANI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FILIPPO MARINO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAURIZIO IACOBONE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MONICA BALDESSIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GIANLUCA CAPPUZZO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SIMONE ZANELLA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GENNARO FAVIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Parathyroid carcinoma is uncommon and no reliable histological markers are available for predicting the clinical outcome of patients. The aim of this study was to assess the correlation between survival, histopatological markers, proliferating cell nuclear antigen (PCNA), Ki-67 antigen and the expression of the p53 nuclear protein in patients with confirmed parathyroid carcinoma (PC). The routine histological specimens from 15 patients (11 men, 4 women, median age 65 years) with confirmed PC who had died of the disease were reviewed. New specimens were also stained with the streptavidin-biotin-peroxidase complex standard technique. The labelling index (LI) of PCNA was quantified by counting 1000 cells from multiple areas in a random fashion, while immunostaining of both Ki-67 and p53 was evaluated as the percentage of positive cells. The PCNA-LI, Ki-67 (%) and p53 (%) values were 14.9±4.1 (median 13, range 2-70), 13.9±3.9 (median 11%, range 3-65%) and 38.5±4.6 (median 29%, range 19-65%), respectively. There was an inverse correlation between age of the patients and p53 (R=-0.73, p=0.002), but no correlation with both PCNA-LI (R=0.07, p=0.72) and Ki-67 (R=-0.07, p=0.79). A significant relationship (R=0.93, p<0.01) between PCNA-LI and Ki-67 was found, while p53 did not correlate with either PCNA-LI (R=-0.11, p=0.71) or Ki-67 (R=-0.05, p=0.86). An inverse correlation (R=-0.63, p=0.01) between survival and the presence of spindle cells and coagulation necrosis together in the standard slides was observed, but there was no correlation (p=NS) between survival and PCNA-LI (R=0.05), Ki-67 (R=0.05) or p53 (R=0.25). In conclusion, none of the tested immunohistochemical markers were useful in predicting the clinical outcome of patients with PC. However, the presence of spindle cells and coagulation necrosis together in the standard specimens should be considered as a negative prognostic factor.

  • Hyperparathyroidism
  • parathyroid carcinoma
  • parathyroid cancer
  • PCNA
  • Ki-67
  • p53

Footnotes

  • Received September 16, 2005.
  • Revision received December 27, 2005.
  • Accepted January 5, 2006.
  • Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 26 (2A)
Anticancer Research
Vol. 26, Issue 2A
March-April 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PCNA-LI, Ki-67 Immunostaining, p53 Activity and Histopathological Variables in Predicting the Clinical Outcome in Patients with Parathyroid Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
PCNA-LI, Ki-67 Immunostaining, p53 Activity and Histopathological Variables in Predicting the Clinical Outcome in Patients with Parathyroid Carcinoma
FRANCO LUMACHI, MARIO ERMANI, FILIPPO MARINO, MAURIZIO IACOBONE, MONICA BALDESSIN, GIANLUCA CAPPUZZO, SIMONE ZANELLA, GENNARO FAVIA
Anticancer Research Mar 2006, 26 (2A) 1305-1308;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
PCNA-LI, Ki-67 Immunostaining, p53 Activity and Histopathological Variables in Predicting the Clinical Outcome in Patients with Parathyroid Carcinoma
FRANCO LUMACHI, MARIO ERMANI, FILIPPO MARINO, MAURIZIO IACOBONE, MONICA BALDESSIN, GIANLUCA CAPPUZZO, SIMONE ZANELLA, GENNARO FAVIA
Anticancer Research Mar 2006, 26 (2A) 1305-1308;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Cancer-induced Hypercalcemia
  • Google Scholar

More in this TOC Section

  • Docosahexaenoic Acid Potentiates the Anticancer Effect of the Menadione/Ascorbate Redox Couple by Increasing Mitochondrial Superoxide and Accelerating ATP Depletion
  • Streptonigrin Mitigates Lung Cancer-induced Cachexia by Suppressing TCF4/TWIST1-induced PTHLH Expression
  • Atezolizumab Retains Cellular Binding to Programmed Death Ligand 1 Following Aerosolization via Mesh Nebulizer
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire